The Antimicrobial Resistance of Candida: A 5-Year Retrospective Analysis at a Tertiary Hospital in Jordan

Anas H Abu-Humaidan1, Areen Alshdaifat1, Dima Awajan2

  • 1Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan.

PubMed

Insights

Antimicrobial resistance in Candida infections is rising globally. This study found non-albicans Candida species in blood samples showed higher resistance, particularly in inpatients, highlighting the need for sample-specific analysis.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Candida infections pose a significant global health challenge.
  • Rising antimicrobial resistance (AMR) complicates treatment strategies.
  • Understanding local prevalence and resistance patterns is crucial for effective management.

Purpose of the Study:

  • To analyze the prevalence and AMR patterns of Candida species in Amman, Jordan.
  • To investigate variations in Candida species distribution and resistance based on sample type and patient status (inpatient vs. outpatient).
  • To inform targeted treatment and surveillance strategies.

Main Methods:

  • Retrospective analysis of electronic microbiology laboratory records from a tertiary teaching hospital (2017-2022).
  • Inclusion of 2673 complete Candida isolate records.
  • Assessment of species identification, sample type, and antimicrobial susceptibility testing (AST) data.

Main Results:

  • Candida albicans was the most common species in vaginal swabs (63.7%), while non-albicans species predominated in blood isolates.
  • Non-albicans species (Pichia kudriavzevii, Nakaseomyces glabratus, Candida parapsilosis) showed higher resistance to Caspofungin compared to C. albicans.
  • Micafungin resistance was significantly higher in inpatient isolates across all pooled samples.

Conclusions:

  • Non-albicans Candida species are significant pathogens in bloodstream infections, exhibiting notable AMR.
  • Antifungal resistance patterns vary by Candida species and sample source, underscoring the importance of source-specific data.
  • Higher Micafungin resistance in inpatients warrants further investigation and may influence empirical treatment choices.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
52.2K
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
867
Genomic DNA in Prokaryotes00:46

Genomic DNA in Prokaryotes

The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...
43.3K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Bacterial Transformation01:33

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
55.0K